175 related articles for article (PubMed ID: 12365577)
1. The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.
Meissner PE; Musoke P; Okwera A; Bunn JE; Coulter JB
Int J Tuberc Lung Dis; 2002 Oct; 6(10):903-8. PubMed ID: 12365577
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Arkansas method of urine testing for isoniazid in South Africa.
Hanifa Y; Mngadi K; Lewis J; Fielding K; Churchyard G; Grant AD
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1232-6. PubMed ID: 17958987
[TBL] [Abstract][Full Text] [Related]
3. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods.
Sirgel FA; Maritz JS; Venter A; Langdon G; Smith PJ; Donald PR
Int J Pharm; 2006 Jan; 307(2):182-7. PubMed ID: 16303269
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
6. Attendance versus compliance with tuberculosis treatment in an occupational setting--a pilot study.
Mqoqi NP; Churchyard GA; Kleinschmidt I; Williams B
S Afr Med J; 1997 Nov; 87(11):1517-21. PubMed ID: 9472274
[TBL] [Abstract][Full Text] [Related]
7. Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.
Manders AJ; Banerjee A; van den Borne HW; Harries AD; Kok GJ; Salaniponi FM
Int J Tuberc Lung Dis; 2001 Sep; 5(9):838-42. PubMed ID: 11573895
[TBL] [Abstract][Full Text] [Related]
8. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.
Fallab-Stubi CL; Zellweger JP; Sauty A; Uldry C; Iorillo D; Burnier M
Int J Tuberc Lung Dis; 1998 Jul; 2(7):525-30. PubMed ID: 9661817
[TBL] [Abstract][Full Text] [Related]
9. Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.
Palanduz A; Gültekin D; Erdem E; Kayaalp N
Ann Trop Paediatr; 2003 Mar; 23(1):47-50. PubMed ID: 12648324
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of compliance with tuberculosis treatment in children: monitoring by urine tests.
Palanduz A; Gultekin D; Kayaalp N
Pediatr Pulmonol; 2003 Jul; 36(1):55-7. PubMed ID: 12772224
[TBL] [Abstract][Full Text] [Related]
11. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
[TBL] [Abstract][Full Text] [Related]
12. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.
Ena J; Valls V
Clin Infect Dis; 2005 Mar; 40(5):670-6. PubMed ID: 15714411
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar.
Rivoire N; Ravololonandriana P; Rasolonavalona T; Martin A; Portaels F; Ramarokoto H; Rasolofo Razanamparany V
Int J Tuberc Lung Dis; 2007 Jun; 11(6):683-8. PubMed ID: 17519102
[TBL] [Abstract][Full Text] [Related]
14. Urine levels of rifampicin & isoniazid in asymptomatic HIV-positive individuals.
Ramachandran G; Hemanth Kumar AK; Sarala K; Padmapriyadarsini C; Anitha S; Tharani CB; Kumaraswami V; Swaminathan S
Indian J Med Res; 2007 Jun; 125(6):763-6. PubMed ID: 17704553
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis.
Higuchi K; Harada N; Mori T
Respirology; 2008 May; 13(3):468-72. PubMed ID: 18399875
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care test to monitor adherence to anti-tuberculous treatment.
Whitfield R; Cope GF
Ann Clin Biochem; 2004 Sep; 41(Pt 5):411-3. PubMed ID: 15333195
[TBL] [Abstract][Full Text] [Related]
17. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
Kuz'min AV; Vasil'eva IA; Chernousova LN
Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
[TBL] [Abstract][Full Text] [Related]
18. Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda.
Lugada ES; Watera C; Nakiyingi J; Elliott A; Brink A; Nanyunja M; French N; Antivelink L; Gilks C; Whitworth J
Int J Tuberc Lung Dis; 2002 Apr; 6(4):326-31. PubMed ID: 11936742
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin.
Chan CH; Or KK; Cheung W; Woo J
J Med; 1995; 26(1-2):43-52. PubMed ID: 7561530
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
